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Mild Hypercholesterolemia
and Premature Heart Disease
In a recent study published in the Journal by Akosah et al. (1), the
investigators found that the presence of borderline or mild hyper-
cholesterolemia has significant effects on the development of
premature coronary heart disease.
In this way, a group of 229 male patients ,50 years of age
(mean age 43 6 5 years), who were admitted to our Coronary Care
Unit as a result of an episode of coronary disease were prospectively
studied. During the acute phase and by means of a structured
questionnaire, the presence of smoking habits, hypertension,
diabetes and dyslipemia were recorded. A physical examination
and fasting analysis were also done. Due to clinical instability or
persistent myocardial ischemia, 132 patients underwent a cardiac
catheterization. In accordance with a previous report (2) we
considered as normolipemia a total cholesterol/HDL cholesterol
ratio (Tchol/HDL) #5. Two groups were established on this
basis. To determine new coronary events, a mean follow-up of
32 6 13 months was carried out. For statistical analysis, the chi
square test and Fisher exact test were applied.
Our study was observational and did not suppose any interven-
tion in the treatment. In the acute phase we found that 160
patients (73%) were smokers; 84 (36%) presented arterial hyper-
tension; 21 (9%) had diabetes; and 181 (77%) had dyslipemia. In
the follow-up, 45 patients (20%) retained smoking habits; 76
(34%) had arterial hypertension; 22 (10%) had diabetes; and 172
(75%) had dyslipemia.
The distribution of coronary lesions in the patients who under-
went a cardiac catheterization were: normal coronariography, 13
patients (10%); one vessel, 49 patients (37%); two vessels, 42
patients (32%); and three vessels, 28 patients (21%).
No differences were found in the prevalence of smoking habits
(93% of our patients were smokers) and diabetes in either group
(Tchol/HDL $5 vs. Tchol/HDL ,5) (3).
Nor were there any differences in the appearance of angina,
myocardial infarction, heart failure, mortality and the need for
coronary revascularization in the follow-up period. Significant data
are shown in Table 1.
We concluded that our patients, who were younger than 50
years of age, with ischemic heart disease, and who showed a
Tchol/HDL ratio #5, present less prevalence of hypertension and
show more frequently an absence of significant coronary lesions in
comparison with those patients with an altered lipid profile.
Furthermore, no additional benefits were found in relation to new
coronary events (fatal and nonfatal). We interpret that this lack of
benefit might be due to the high percentage of smokers in both
groups. Finally, our data are coincident with those reported
previously (4), showing that a normal lipid profile does not confer
additional benefit to smokers.
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REPLY
Batalla and colleagues found in a sample of 220 Spanish men with
coronary heart disease that frequencies of epsilon43 and epsilon44
genotypes did not differ from those among 200 age-matched
controls. In contrast, we observed in the Danish population (by
comparing genotype frequencies in 693 male patients with those
among 4,129 men sampled from the general population) that the
epsilon43 and epsilon44 genotypes compared with the wild-type
epsilon33 genotype in men predicted 40% and 60% increases in
risk of ischemic heart disease, respectively (1).
It is well established that there is a north-to-south decreasing
gradient of the epsilon4 allele frequency throughout Europe (2,3).
This is exemplified by an epsilon4 relative allele frequency of 17%
in the Danish population (1) versus 8% in the Spanish population,
as demonstrated by Batalla et al. We agree that the lower frequency
of the epsilon4 allele in Southern versus Northern Europe may
Table 1. Differences Between Normolipemic and
Hyperlipemic Patients
Tchol/HDL
<5 (n 5 39)
Tchol/HDL
>5 (n 5 190)
p
Value
Hypertension 7 (18%) 77 (40%) 0.007
Normal coronariography 6 (30%) 7 (6%) ,0.005
HDL 5 high density lipoprotein; Tchol 5 total cholesterol.
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